Literature DB >> 26440445

Detecting glaucomatous change in visual fields: Analysis with an optimization framework.

Siamak Yousefi1, Michael H Goldbaum1, Ehsan S Varnousfaderani1, Akram Belghith1, Tzyy-Ping Jung2, Felipe A Medeiros1, Linda M Zangwill1, Robert N Weinreb1, Jeffrey M Liebmann3, Christopher A Girkin4, Christopher Bowd5.   

Abstract

Detecting glaucomatous progression is an important aspect of glaucoma management. The assessment of longitudinal series of visual fields, measured using Standard Automated Perimetry (SAP), is considered the reference standard for this effort. We seek efficient techniques for determining progression from longitudinal visual fields by formulating the problem as an optimization framework, learned from a population of glaucoma data. The longitudinal data from each patient's eye were used in a convex optimization framework to find a vector that is representative of the progression direction of the sample population, as a whole. Post-hoc analysis of longitudinal visual fields across the derived vector led to optimal progression (change) detection. The proposed method was compared to recently described progression detection methods and to linear regression of instrument-defined global indices, and showed slightly higher sensitivities at the highest specificities than other methods (a clinically desirable result). The proposed approach is simpler, faster, and more efficient for detecting glaucomatous changes, compared to our previously proposed machine learning-based methods, although it provides somewhat less information. This approach has potential application in glaucoma clinics for patient monitoring and in research centers for classification of study participants.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Change detection; Computational modeling; Data mining; Glaucoma; Progression; Standard automated perimetry; Visual field

Mesh:

Year:  2015        PMID: 26440445      PMCID: PMC4684767          DOI: 10.1016/j.jbi.2015.09.019

Source DB:  PubMed          Journal:  J Biomed Inform        ISSN: 1532-0464            Impact factor:   6.317


  21 in total

1.  Interobserver agreement and intraobserver reproducibility of the subjective determination of glaucomatous visual field progression.

Authors:  Angelo P Tanna; Jagadeesh R Bandi; Donald L Budenz; William J Feuer; Robert M Feldman; Leon W Herndon; Douglas J Rhee; Julia Whiteside-de Vos
Journal:  Ophthalmology       Date:  2010-08-17       Impact factor: 12.079

2.  A multichannel Markov random field approach for automated segmentation of breast cancer tumor in DCE-MRI data using kinetic observation model.

Authors:  Ahmed B Ashraf; Sara Gavenonis; Dania Daye; Carolyn Mies; Michael Feldman; Mark Rosen; Despina Kontos
Journal:  Med Image Comput Comput Assist Interv       Date:  2011

3.  Trained artificial neural network for glaucoma diagnosis using visual field data: a comparison with conventional algorithms.

Authors:  Dimitrios Bizios; Anders Heijl; Boel Bengtsson
Journal:  J Glaucoma       Date:  2007-01       Impact factor: 2.503

4.  Estimating progression of visual field loss in glaucoma.

Authors:  J Katz; D Gilbert; H A Quigley; A Sommer
Journal:  Ophthalmology       Date:  1997-06       Impact factor: 12.079

5.  Learning from data: recognizing glaucomatous defect patterns and detecting progression from visual field measurements.

Authors:  Siamak Yousefi; Michael H Goldbaum; Madhusudhanan Balasubramanian; Felipe A Medeiros; Linda M Zangwill; Jeffrey M Liebmann; Christopher A Girkin; Robert N Weinreb; Christopher Bowd
Journal:  IEEE Trans Biomed Eng       Date:  2014-04-01       Impact factor: 4.538

6.  Recognizing patterns of visual field loss using unsupervised machine learning.

Authors:  Siamak Yousefi; Michael H Goldbaum; Linda M Zangwill; Felipe A Medeiros; Christopher Bowd
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2014-03-21

7.  Analysis of visual field progression in glaucoma.

Authors:  F W Fitzke; R A Hitchings; D Poinoosawmy; A I McNaught; D P Crabb
Journal:  Br J Ophthalmol       Date:  1996-01       Impact factor: 4.638

8.  A visual field index for calculation of glaucoma rate of progression.

Authors:  Boel Bengtsson; Anders Heijl
Journal:  Am J Ophthalmol       Date:  2008-02       Impact factor: 5.258

Review 9.  The pathophysiology and treatment of glaucoma: a review.

Authors:  Robert N Weinreb; Tin Aung; Felipe A Medeiros
Journal:  JAMA       Date:  2014-05-14       Impact factor: 56.272

10.  Visual field progression in glaucoma: estimating the overall significance of deterioration with permutation analyses of pointwise linear regression (PoPLR).

Authors:  Neil O'Leary; Balwantray C Chauhan; Paul H Artes
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-01       Impact factor: 4.799

View more
  4 in total

1.  Comparing 10-2 and 24-2 Visual Fields for Detecting Progressive Central Visual Loss in Glaucoma Eyes with Early Central Abnormalities.

Authors:  Zhichao Wu; Felipe A Medeiros; Robert N Weinreb; Christopher A Girkin; Linda M Zangwill
Journal:  Ophthalmol Glaucoma       Date:  2019-01-14

2.  Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence-Enabled Dashboard.

Authors:  Siamak Yousefi; Tobias Elze; Louis R Pasquale; Osamah Saeedi; Mengyu Wang; Lucy Q Shen; Sarah R Wellik; Carlos G De Moraes; Jonathan S Myers; Michael V Boland
Journal:  Ophthalmology       Date:  2020-03-10       Impact factor: 12.079

3.  Novel Machine-Learning Based Framework Using Electroretinography Data for the Detection of Early-Stage Glaucoma.

Authors:  Mohan Kumar Gajendran; Landon J Rohowetz; Peter Koulen; Amirfarhang Mehdizadeh
Journal:  Front Neurosci       Date:  2022-05-04       Impact factor: 5.152

4.  Comparison of Saccadic Vector Optokinetic Perimetry and Standard Automated Perimetry in Glaucoma. Part I: Threshold Values and Repeatability.

Authors:  Ian C Murray; Antonios Perperidis; Lorraine A Cameron; Alice D McTrusty; Harry M Brash; Andrew J Tatham; Pankaj K Agarwal; Brian W Fleck; Robert A Minns
Journal:  Transl Vis Sci Technol       Date:  2017-09-06       Impact factor: 3.283

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.